mGluR5 Negative Allosteric Modulators Overview: A Medicinal Chemistry Approach Towards a Series of Novel Therapeutic Agents

By  

Current Topics in Medicinal Chemistry, Vol. 11, Iss. 6, 2011-03 ,pp. : 680-695

Bentham Science Publishers

Access to resources Recommend Favorite

Recent advances in the drug discovery of metabotropic glutamate receptor 4 (mGluR4) activators for the treatment of CNS and non-CNS disorders

By Célanire Sylvain   Campo Brice  

Expert Opinion on Drug Discovery, Vol. 7, Iss. 3, 2012-03 ,pp. : 261-280

Informa Healthcare

Access to resources Recommend Favorite

2,4-Dicarboxy-pyrroles as selective non-competitive mGluR1 antagonists: an exploration of the role of the pyrrolic scaffold

By Micheli F.   Di Fabio R.   Cavanni P.   Donati D.   Faedo S.   Gehanne S.   Maffeis M.   Marchioro C.   Sabbatini F.M.   Tarzia G.   Tranquillini M.E.   Viziano M.  

Il Farmaco, Vol. 58, Iss. 10, 2003-10 ,pp. : 1005-1009

Elsevier

Access to resources Recommend Favorite

Galanin Receptor Antagonists: A Potential Novel Pharmacological Treatment for Mood Disorders

By Ögren Sven Ove   Kuteeva Eugenia   Hökfelt Tomas   Kehr Jan  

CNS Drugs, Vol. 20, Iss. 8, 2006-01 ,pp. : 633-654

Adis International

Access to resources Recommend Favorite

GABA B receptor agonists and antagonists: pharmacological properties and therapeutic possibilities

By Enna S.  

Expert Opinion on Investigational Drugs, Vol. 6, Iss. 10, 1997-10 ,pp. : 1319-1326

Informa Healthcare

Access to resources Recommend Favorite